Generalized Pustular Psoriasis (GPP) Control Is Limited on Traditional Small-Molecule Therapy As Measured by the GPP Physician Global Assessment (GPPGA) and Dermatology Life Quality Index (DLQI): Baseline Data from the EFFISAYIL® 2 Trial. J of Skin 2025, 9 (2), s540. https://doi.org/10.25251/skin.10.supp.540.